Adagio Medical gets Nasdaq notice for failing $2.5 million stockholders’ equity requirement

PUBT · 1d ago
Adagio Medical gets Nasdaq notice for failing $2.5 million stockholders’ equity requirement
  • Adagio Medical received a Nasdaq deficiency notice on Aug. 13, 2026 for failing the $2.5 million minimum stockholders’ equity rule.
  • Stockholders’ equity was USD -415,000 in its Form 10-Q for the quarter ended June 30, 2026.
  • Nasdaq gave 45 days, by Sept. 28, 2026, to submit a compliance plan; an accepted plan could allow up to 180 days to cure.
  • Failure to win plan acceptance could trigger a delisting determination, with an option to appeal to a Nasdaq hearings panel.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Adagio Medical Holdings Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001104659-26-097242), on August 14, 2026, and is solely responsible for the information contained therein.